Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer

被引:14
作者
Yun, Chen [2 ]
Gang, Li [1 ]
Gu Rongmin [1 ]
Xu, Wen [1 ]
Ming Xuezhi [1 ]
Chen Huanqiu [1 ]
机构
[1] Nanjing Med Univ, Dept Gen Surg, Gastr Tumor Ctr, Jiangsu Canc Hosp,Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210009, Jiangsu, Peoples R China
基金
中国博士后科学基金;
关键词
Her2; Her3; Met; gastric cancer; BREAST-CANCER; TARGETED THERAPIES; RECEPTOR; RESISTANCE; MECHANISMS;
D O I
10.1002/mc.22241
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various receptor tyrosine kinase (RTK) pathways were verified in many cancers including gastric cancer (GC), We sought to investigate the expression of RTKs including Her2, Her3, and Met and their transduction patterns in human GC. Over-expression of Her2, Her3, and c-Met in human GC was verified by immunohistochemistry leading to constitutive activation of RTK signaling pathways. Combined RTKs expression was valuable indicators for poor prognosis of GC patients. Using ErbB2 specific inhibitor Lapatinib and c-Met specific inhibitor PHA-665752, we further demonstrated that this constitutive activation of RTK signaling is necessary for the survival of GC cells. However, various RTK pattern: Her3/Her2 and Met/Her3 were verified in the transduction growth stimulus from outside via both AKT and MAPK signaling. Moreover, the essential roles of Her3 in both two heterodimers were obtained which showed significantly attenuated growth effect due to Her3 knockdown both in vitro and in vivo. In conclusion, various molecular transduction patterns: Her2/Her3 and Met/Her3 were verified in human GC, and Her3 could serve as a potential target in GC treatment. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1700 / 1709
页数:10
相关论文
共 25 条
[1]   Modulation of c-Met signaling and cellular sensitivity to radiation Potential Implications for Therapy [J].
Bhardwaj, Vikas ;
Cascone, Tina ;
Cortez, Maria Angelica ;
Amini, Arya ;
Evans, Jaden ;
Komaki, Ritsuko U. ;
Heymach, John V. ;
Welsh, James W. .
CANCER, 2013, 119 (10) :1768-1775
[2]  
Bradshaw R. A., 2013, Advances in Biological Regulation, V53, P87, DOI 10.1016/j.jbior.2012.10.006
[3]   Targeting the HGF/Met signaling pathway in cancer therapy [J].
Cecchi, Fabiola ;
Rabe, Danie C. ;
Bottaro, Donald P. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (06) :553-572
[4]   Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma [J].
Chand, Damini ;
Yamazaki, Yasuo ;
Ruuth, Kristina ;
Schonherr, Christina ;
Martinsson, Tommy ;
Kogner, Per ;
Attiyeh, Edward F. ;
Maris, John ;
Morozova, Olena ;
Marra, Marco A. ;
Ohira, Miki ;
Nakagawara, Akira ;
Sandstrom, Per-Erik ;
Palmer, Ruth H. ;
Hallberg, Bengt .
DISEASE MODELS & MECHANISMS, 2013, 6 (02) :373-382
[5]   When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene [J].
Chow, Amy ;
Arteaga, Carlos L. ;
Wang, Shizhen Emily .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2011, 16 (02) :81-88
[6]   Gastric Cancer: Overview [J].
Correa, Pelayo .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2013, 42 (02) :211-+
[7]   HER2 therapies and gastric cancer: A step forward [J].
de Mello, Ramon Andrade ;
Marques, Andrea Marin ;
Araujo, Antonio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (37) :6165-6169
[8]   Current status of targeted therapies in advanced gastric cancer [J].
De Vita, Ferdinando ;
Giuliani, Francesco ;
Silvestris, Nicola ;
Rossetti, Sabrina ;
Pizzolorusso, Antonio ;
Santabarbara, Giuseppe ;
Galizia, Gennaro ;
Colucci, Giuseppe ;
Ciardiello, Fortunato ;
Orditura, Michele .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 :S29-S34
[9]  
DeDosso S, 2013, CANC METASTASIS REV
[10]  
Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31